Reviewing the Skin Cancer Pipeline: A Look at the Last 10 Years
Source: Dermatology Times, May 2024
In recognition of Skin Cancer Awareness Month, Dermatology Times is reviewing research and strides in skin cancer treatment over the last decade.
The US Food and Drug Administration (FDA) has approved several therapies for patients with skin cancer over the years. From innovations such as combination therapy approvals to the clearance of artificial intelligence devices, research and stamps of approval have led to significant improvements in patient care.
This Skin Cancer Awareness Month, Dermatology Times is recapping the last 10 years of news in the skin cancer drug pipeline.